Doxycycline for the prevention of progression of COVID-19 to severe disease requiring intensive care unit (ICU) admission: A randomized, controlled, open-label, parallel group trial (DOXPREVENT.ICU).
<h4>Background</h4>After admission to hospital, COVID-19 progresses in a substantial proportion of patients to critical disease that requires intensive care unit (ICU) admission.<h4>Methods</h4>In a pragmatic, non-blinded trial, 387 patients aged 40-90 years were randomised t...
Główni autorzy: | Raja Dhar, John Kirkpatrick, Laura Gilbert, Arjun Khanna, Mahavir Madhavdas Modi, Rakesh K Chawla, Sonia Dalal, Venkata Nagarjuna Maturu, Marcel Stern, Oliver T Keppler, Ratko Djukanovic, Stephan D Gadola |
---|---|
Format: | Artykuł |
Język: | English |
Wydane: |
Public Library of Science (PLoS)
2023-01-01
|
Seria: | PLoS ONE |
Dostęp online: | https://doi.org/10.1371/journal.pone.0280745 |
Podobne zapisy
-
ICU Survivors Experience of ICU Diaries: An Ancillary Qualitative Analysis of the ICU Diary Study
od: Cécile Flahault, PhD, i wsp.
Wydane: (2021-05-01) -
Variation in rates of ICU readmissions and post-ICU in-hospital mortality and their association with ICU discharge practices
od: Nelleke van Sluisveld, i wsp.
Wydane: (2017-04-01) -
Plasmapheresis in the ICU
od: Guleid Hussein, i wsp.
Wydane: (2023-12-01) -
The ICU Book
od: Karin Nollain
Wydane: (2008-03-01) -
Biofilms in the ICU
od: Kendra P Rumbaugh
Wydane: (2014-04-01)